Novidin (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Novidin, is a vasopressin analog presented as an oral formulation for oral use. It is employed to manage central diabetes insipidus, nocturnal enuresis, hemophilia A, and von Willebrand disease. GNH USA supplies Novidin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin Acetate acts on the antidiuretic hormone pathway and is used for several recognised conditions.

Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption. Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adults. Hemophilia A: raises plasma factor VIII levels to improve clotting. Von Willebrand disease: increases von Willebrand factor levels, aiding platelet adhesion.

Desmopressin Acetate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea or abdominal discomfort. - Nasal congestion or rhinorrhoea. - Mild hyponatraemia: low serum sodium without severe symptoms. - Flushing or warmth sensation.

Serious or Rare Side Effects: - Severe hyponatraemia with seizures or coma. - Water intoxication leading to cerebral oedema. - Allergic reactions such as rash, urticaria, or anaphylaxis. - Thromboembolic events in patients with high factor VIII levels. - Uncontrolled hypertension or cardiac overload.

Before initiating therapy with Desmopressin Acetate, consider the following safety measures.

Assess fluid balance: monitor intake and output to avoid water overload. Monitor serum sodium: check levels regularly, especially in the first weeks. Use caution in renal impairment: dose adjustment may be required. Avoid in uncontrolled hypertension: the drug can increase intravascular volume. Adjust dose for elderly patients: they are more susceptible to hyponatraemia. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Desmopressin Acetate can interact with several medicines; some combinations should be avoided while others need close monitoring.

Major Interactions (Avoid): - Carbamazepine: reduces desmopressin effectiveness. - MAO inhibitors: increase risk of severe hyponatraemia. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potentiate water retention and hyponatraemia. - Thiazide diuretics: synergistic effect on water reabsorption leading to hyponatraemia.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may modestly raise hyponatraemia risk. - Anticonvulsants such as valproate: can alter fluid balance. - ACE inhibitors or ARBs: monitor blood pressure and electrolytes.